Emily E. Weber LeBrun

Emily E. Weber LeBrun

Auto-generated profile, based on publicly available information

Emily E. Weber LeBrun

University of Florida College of Medicine, Gainesville, FL

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
TSTatiana V.D. Sanses
Tatiana V.D. Sanses
ASAzin Shahryarinejad
Azin Shahryarinejad
SMStephanie Molden
Stephanie Molden
KHKay A. Hoskey
Kay A. Hoskey
SAShameem Abbasy
Shameem Abbasy
SYStephen B. Young
Stephen B. Young

1 March 2016 in Urogynecology
Verified
Journal Article
Closed access
CBCatherine S. Md Bradley
Catherine S. Md Bradley
AVAnthony G. Visco
Anthony G. Visco
ELEmily E. Weber LeBrun
Emily E. Weber LeBrun
MBMatthew D. Md Barber
Matthew D. Md Barber
Pelvic organ prolapse (POP) is a common problem that negatively impacts women's quality of life. A variety of surgeries exist for POP treatment, including procedures performed with and without mesh augmentation. The growing use of mesh in prolapse surgeries in the 2000s was associated with increasing reports of complications, resulting in Food and Drug Administration (FDA) Safety Notifications, and in 2012, the FDA ordered transvaginal mesh manufacturers to conduct prospective studies to evaluate longer-term outcomes. These requirements provided incentives and an environment conducive to collaboration. American Urogynecologic Society leaders collaborated with device manufacturers, the FDA, and other professional organizations to establish the Pelvic Floor Disorders Registry (PFDR), a collection of interrelated registries, which could meet manufacturers' needs but also allow surgeons to track individual and aggregate outcomes for quality improvement. The PFDR was developed and launched by American Urogynecologic Society with objectives of (1) collecting, storing, and analyzing clinical data related to POP treatment; (2) establishing common data elements and quality metrics; and (3) providing a framework for external stakeholders to conduct POP research. The PFDR includes industry-sponsored studies, as well as 2 options for volunteer registry participation, the PFDR-Quality Improvement and PFDR-Research. The PFDR promotes quality improvement and national benchmarking and will provide real-world comparative safety and effectiveness data for prolapse surgeries. The PFDR can serve as a model for collaboration between medical practitioners, researchers, industry, and federal agencies and may allow progress toward our similar goal of high-quality surgical care of women with prolapse.

1 March 2016 in Urogynecology
Verified
Journal Article
Closed access
ELEmily Weber LeBrun
Emily Weber LeBrun
RARony A. Adam
Rony A. Adam
MBMatthew D. Barber
Matthew D. Barber
SBSarah Hamilton Boyles
Sarah Hamilton Boyles
CICheryl B. Iglesia
Cheryl B. Iglesia
CBCatherine S. Bradley
Catherine S. Bradley
Pelvic floor disorders affect up to 24% of adult women in the United States, and many patients with pelvic organ prolapse (POP) choose to undergo surgical repair to improve their quality of life. While a variety of surgical repair approaches and techniques are utilized, including mesh augmentation, there is limited comparative effectiveness and safety outcome data guiding best practice. In conjunction with device manufacturers, federal regulatory organizations, and professional societies, the American Urogynecologic Society developed the Pelvic Floor Disorders Registry (PFDR) designed to improve the quality of POP surgery by facilitating quality improvement and research on POP treatments. The PFDR will serve as a resource for surgeons interested in benchmarking and outcomes data and as a data repository for Food and Drug Administration-mandated POP surgical device studies. Provider-reported clinical data and patient-reported outcomes will be collected prospectively at baseline and for up to 3 years after treatment. All data elements including measures of success, adverse events, and surgeon characteristics were identified and defined within the context of the anticipated multifunctionality of the registry, and with collaboration from multiple stakeholders. The PFDR will provide a platform to collect high-quality, standardized patient-level data from a variety of nonsurgical (pessary) and surgical treatments of POP and other pelvic floor disorders. Data from this registry may be used to evaluate short- and longer-term treatment outcomes, patient-reported outcomes, and complications, as well as to identify factors associated with treatment success and failure with the overall goal of improving the quality of care for women with these conditions.

1 February 2015 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
PJPeter C. Jeppson
Peter C. Jeppson
SRSalma Rahimi
Salma Rahimi
LGLeda Gattoc
Leda Gattoc
LWLauren B. Westermann
Lauren B. Westermann
SCSara Cichowski
Sara Cichowski
VSVivian W. Sung
Vivian W. Sung

1 July 2020 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
ELEmily E. Weber LeBrun
Emily E. Weber LeBrun
NMNash S. Moawad
Nash S. Moawad
EREric I. Rosenberg
Eric I. Rosenberg
TMTimothy E. Morey
Timothy E. Morey
LDLaurie Davies
Laurie Davies
JSJohn C. Smulian
John C. Smulian

1 March 2015 in Sexual Medicine
Verified
Journal Article
Open access
PDF file
MAMeryl J. Alappattu
Meryl J. Alappattu
SGSteven Z. George
Steven Z. George
MRMichael E. Robinson
Michael E. Robinson
RFRoger B Fillingim
Roger B Fillingim
NMNash S. Moawad
Nash S. Moawad
MBMark D. Bishop
Mark D. Bishop
Introduction Evidence suggests that painful intercourse, pain-related psychosocial factors, and altered pain processing magnify the pain experience, but it is not clear how these factors are related to each other. Aim The aims were to (i) characterize differences between women with pelvic pain and pain-free women using a battery of pain-related psychosocial measures, clinical pain ratings, and evoked local and remote pain sensitivity; and (ii) examine the relationship between intercourse pain, clinical pain, and local and remote evoked pain sensitivity. Methods Women with pelvic pain lasting at least 3 months and pain-free women completed questionnaires and underwent pain sensitivity testing. Self-report measures included clinical pain intensity, pain catastrophizing, pain-related fear, pain anxiety, depression, sexual function, and self-efficacy. Pain sensitivity measures included threshold and tolerance and temporal summation of pain. Separate analyses of variance (anova) were used to test group differences in self-report and pain sensitivity measures. Correlations were calculated among dyspareunia, psychosocial factors, and evoked pain. Main Outcome Measures Self-reported pain and pain sensitivity measures. Results Twenty-eight pain-free women and 14 women with pelvic pain participated in this study. Women with pelvic pain reported greater pain intensity and greater psychosocial involvement compared with pain-free women. No differences existed between groups for thermal or pressure measures, but women with pelvic pain rated their pain with pain testing significantly higher than pain-free women. Intercourse pain was significantly associated with affective and sensory pain and pressure pain ratings at the puborectalis, vulvar vestibule, adductor longus tendons, and tibialis anterior muscle. Conclusions Differences in local pain ratings suggest that women with pelvic pain perceive stimuli in this region as more painful than pain-free women although the magnitude of stimuli does not differ. Alappattu MJ, George SZ, Robinson ME, Fillingim RB, Moawad N, LeBrun EW, and Bishop MD. Painful intercourse is significantly associated with evoked pain perception and cognitive aspects of pain in women with pelvic pain. Sex Med 2015;3:14–23.